Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Vaso-occlusive Crisis: full-pipeline trial registry

2 of 5 indexed Vaso-occlusive Crisis trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Vaso-occlusive Crisis: 5 US clinical trials tracked, 2 recruiting.

Vaso-occlusive Crisis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is St. Jude Children's Research Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition vaso-occlusive-crisis

OPEN 2 | RECR 40% | LATE 2 | EARLY 2 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Vaso-occlusive Crisis (this)40%
Open-enrollment share among volume-matched conditions near Vaso-occlusive Crisis

Vaso-occlusive Crisis lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vaso-occlusive Crisis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vaso-occlusive Crisis is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Vaso-occlusive Crisis research.

    St. Jude Children's Research Hospital accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Vaso-occlusive Crisis trials plan to enrol fewer than 100 people.

    Median target enrolment is 34 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Vaso-occlusive Crisis research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 32

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 2

Named interventions

Most-linked intervention names on Vaso-occlusive Crisis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
Inclacumab Drug
1 trials
Nitrous oxide 50% Drug
1 trials
Dalteparin Drug
1 trials
Virtual Reality Therapy Other
1 trials
Ketamine Hydrochloride Drug
1 trials

US sites by state

Facility locations filed on Vaso-occlusive Crisis trials. A trial with sites in several states counts in each.

New York 2 trials
North Carolina 2 trials
Massachusetts 2 trials
Texas 1 trials
Tennessee 1 trials
Michigan 1 trials
Illinois 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vaso-occlusive Crisis page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vaso-occlusive Crisis condition card totals 5 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.